153 related articles for article (PubMed ID: 23561982)
41. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.
Fusar-Poli P; Howes OD; Allen P; Broome M; Valli I; Asselin MC; Grasby PM; McGuire PK
Arch Gen Psychiatry; 2010 Jul; 67(7):683-91. PubMed ID: 20603449
[TBL] [Abstract][Full Text] [Related]
42. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
[TBL] [Abstract][Full Text] [Related]
43. [Parkinson disease and cognition].
Kulisevsky J; Pascual-Sedano B
Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
[TBL] [Abstract][Full Text] [Related]
44. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.
Nobili F; Campus C; Arnaldi D; De Carli F; Cabassi G; Brugnolo A; Dessi B; Morbelli S; Sambuceti G; Abbruzzese G; Rodriguez G
Mov Disord; 2010 Jan; 25(1):35-43. PubMed ID: 20058228
[TBL] [Abstract][Full Text] [Related]
45. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.
Zgaljardic DJ; Borod JC; Foldi NS; Mattis P
Cogn Behav Neurol; 2003 Dec; 16(4):193-210. PubMed ID: 14665819
[TBL] [Abstract][Full Text] [Related]
46. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
[TBL] [Abstract][Full Text] [Related]
47. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
[TBL] [Abstract][Full Text] [Related]
48. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
49. Mortality in Parkinson's disease is not associated with the severity of early dopaminergic defect.
Järvelä JT; Rinne JO; Eskola O; Kaasinen V
Parkinsonism Relat Disord; 2014 Aug; 20(8):894-7. PubMed ID: 24928032
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of dopaminergic presynaptic function by [F-18] DOPA PET].
Kato T
Rinsho Shinkeigaku; 2007 Nov; 47(11):829-31. PubMed ID: 18210809
[TBL] [Abstract][Full Text] [Related]
51. The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.
MacDonald PA; MacDonald AA; Seergobin KN; Tamjeedi R; Ganjavi H; Provost JS; Monchi O
Brain; 2011 May; 134(Pt 5):1447-63. PubMed ID: 21596772
[TBL] [Abstract][Full Text] [Related]
52. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
Rektorova I; Srovnalova H; Kubikova R; Prasek J
Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
[TBL] [Abstract][Full Text] [Related]
53. Prepulse inhibition is associated with attention, processing speed, and 123I-FP-CIT SPECT in Parkinson's disease.
Zoetmulder M; Biernat HB; Nikolic M; Korbo L; Friberg L; Jennum PJ
J Parkinsons Dis; 2014; 4(1):77-87. PubMed ID: 24366928
[TBL] [Abstract][Full Text] [Related]
54. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
55. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.
Jentsch JD; Taylor JR; Elsworth JD; Redmond DE; Roth RH
Neuroscience; 1999 Mar; 90(3):823-32. PubMed ID: 10218783
[TBL] [Abstract][Full Text] [Related]
56. Executive processes in Parkinson's disease: FDG-PET and network analysis.
Lozza C; Baron JC; Eidelberg D; Mentis MJ; Carbon M; Marié RM
Hum Brain Mapp; 2004 Jul; 22(3):236-45. PubMed ID: 15195290
[TBL] [Abstract][Full Text] [Related]
57. Relationship of striatal dopamine synthesis capacity to age and cognition.
Braskie MN; Wilcox CE; Landau SM; O'Neil JP; Baker SL; Madison CM; Kluth JT; Jagust WJ
J Neurosci; 2008 Dec; 28(52):14320-8. PubMed ID: 19109513
[TBL] [Abstract][Full Text] [Related]
58. Improving response inhibition in Parkinson's disease with atomoxetine.
Ye Z; Altena E; Nombela C; Housden CR; Maxwell H; Rittman T; Huddleston C; Rae CL; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Biol Psychiatry; 2015 Apr; 77(8):740-8. PubMed ID: 24655598
[TBL] [Abstract][Full Text] [Related]
59. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography.
Elliott R; Baker SC; Rogers RD; O'Leary DA; Paykel ES; Frith CD; Dolan RJ; Sahakian BJ
Psychol Med; 1997 Jul; 27(4):931-42. PubMed ID: 9234470
[TBL] [Abstract][Full Text] [Related]
60. Optic nerve integrity as a visuospatial cognitive predictor in Parkinson's disease.
Lee JJ; Shin NY; Lee Y; Lee SK; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2016 Oct; 31():41-45. PubMed ID: 27394650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
